Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

AIDS

Volumn 18, Issue 17, 2004, Pages 2337-2339

  Thorne, Claire ^a   Patel, Deven ^a   Newell, Marie Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CESAREAN SECTION; ETHNIC GROUP; EUROPE; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN MORTALITY; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME; VAGINAL DELIVERY;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RISK FACTORS;

EID: 10244236453     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200411190-00019     Document Type: Article

References (5)

1. Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind, C, Rudin C, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998; 12:F241-F247.
2. European Collaborative Study and the Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14:2913-2920.
3. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:380-387.
4. Tuomala R, Shapiro DE, Mofenson L, Bryson Y, Culnane M, Hughes MD, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002; 346:1863-1870.
5. Newell ML, Rogers M (editors). Pregnancy and HIV infection: a European Consensus on management. AIDS 2002; 16 (Suppl. 2): S1-S18.